Tan, Jinshui
Zhong, Mengya
Hu, Yanyan
Pan, Guangchao
Yao, Jingwei
Tang, Yuanfang
Duan, Hongpeng
Jiang, Yuelong
Shan, Weihang
Lin, Jiaqi
Liu, Yating
Huang, Jiewen
Zheng, Huijian
Zhou, Yong
Fu, Guo
Li, Zhifeng
Xu, Bing
Zha, Jie
Funding for this research was provided by:
National Natural Science Foundation of China (U22A20290, 82170180, 81800163)
Natural Science Foundation of Fujian Province (2019J0105, 2020J011246, 2020GGB054, 2021J011359)
Xiamen Municipal Bureau of Science and Technology (3502Z20209003, 3502Z20209008)
Article History
Received: 14 April 2023
Accepted: 25 June 2023
First Online: 1 July 2023
Declarations
:
: All patients provided written informed consent for the use of their specimens and disease information for future research following the Ethics Review Committee of the First Affiliated Hospital of Xiamen University, and under the tenets of the Declaration of Helsinki. Animal procedures were approved by the Laboratory Animal Ethics and Management Committee of Xiamen University following the principles and procedures of the NIH Guidelines for Endpoints in Animal Study Proposals (Approval Code: XMULAC20170065, 28 February 2017). The weight loss of mice in all animal experiments should be less than 20% of the body weight, not exceeding the limits specified in the NIH Guidelines for Endpoints in Animal Study Proposals.
: The authors declare that they have no competing interests.